AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) financial statements, including revenue, expenses, and profit
The total revenue of 0A8M for the last quarter is 16.22 M USD, and it's 2.13% lower compared to the previous quarter. The net income of Q2 25 is 788.00 k USD.